Alimera Sciences reported $-4352000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Alimera Sciences ALIM:US $ -4.35M 10.06M
Applied Genetic Technologies AGTC:US $ -17.09M 2.8M
Insmed INSM:US $ -115292000 1.41M
Novartis NOVN:VX SF 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M